A detailed history of Crewe Advisors LLC transactions in Mckesson Corp stock. As of the latest transaction made, Crewe Advisors LLC holds 498 shares of MCK stock, worth $290,812. This represents 0.03% of its overall portfolio holdings.

Number of Shares
498
Previous 896 44.42%
Holding current value
$290,812
Previous $523,000 52.96%
% of portfolio
0.03%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$479.06 - $630.38 $190,665 - $250,891
-398 Reduced 44.42%
498 $246,000
Q2 2024

Jul 29, 2024

SELL
$518.81 - $607.81 $6,225 - $7,293
-12 Reduced 1.32%
896 $523,000
Q1 2024

May 13, 2024

BUY
$473.42 - $539.26 $429,865 - $489,648
908 New
908 $487,000
Q2 2023

Jul 28, 2023

BUY
$354.01 - $427.31 $354 - $427
1 Added 0.54%
186 $79,000
Q1 2023

May 12, 2023

SELL
$335.35 - $386.06 $23,809 - $27,410
-71 Reduced 27.73%
185 $65,000
Q4 2022

Feb 07, 2023

SELL
$346.68 - $397.58 $23,920 - $27,433
-69 Reduced 21.23%
256 $96,000
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $8,673 - $10,093
27 Added 9.06%
325 $110,000
Q2 2022

Aug 02, 2022

BUY
$300.57 - $336.42 $18,935 - $21,194
63 Added 26.81%
298 $97,000
Q1 2022

Apr 27, 2022

BUY
$244.61 - $310.48 $12,230 - $15,524
50 Added 27.03%
235 $72,000
Q3 2021

Oct 29, 2021

SELL
$188.42 - $208.66 $9,986 - $11,058
-53 Reduced 22.27%
185 $37,000
Q2 2021

Aug 11, 2021

SELL
$184.89 - $202.68 $9,984 - $10,944
-54 Reduced 18.49%
238 $46,000
Q4 2020

Jan 27, 2021

SELL
$143.79 - $183.66 $3,019 - $3,856
-21 Reduced 6.71%
292 $51,000
Q3 2020

Oct 13, 2020

BUY
$140.89 - $159.9 $18,033 - $20,467
128 Added 69.19%
313 $47,000
Q4 2017

Feb 09, 2018

BUY
$135.02 - $162.6 $24,978 - $30,081
185
185 $29,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.